Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Business Practice

Manufacture Advanced Medicine

The Patient Experience Trumps All

| Cedric Picaud | 3 min read

How can companies realistically incorporate patient-centric practices into cell and gene product development?

Business & Regulation Business Practice

Improving the Pharma Industry

| Stephanie Sutton | 3 min read

Five members of The Medicine Maker’s 2022 Power List share their thoughts on how the pharma industry can improve.

Business & Regulation Trends & Forecasts

The Headset Mindset

| Angus Stewart | 8 min read

As the ATMP hiring market struggles through the Great Resignation, can VR take us back to the future?

Business & Regulation Digital Technologies

Pharmaceutical Sales Strategy: AI for All

| Alan Kalton | 3 min read

AI is making waves across industries, but what impact will it have on pharmaceutical marketing?

Business & Regulation Business Practice

Patents: Why Pharma & the High Tech Sector Should Collaborate

| Joerg Thomaier | 6 min read

Why pharma and the high tech sector should band together for the sake of innovation.

Business & Regulation Business Practice

Drug Price Reforms in the US: Good or Bad?

| Stephanie Sutton | 3 min read

Change is in the air for drug pricing in the US after the Senate passes the Inflation Reduction Act.

Business & Regulation Business Practice

Staying Engaged

| Maryam Mahdi | 3 min read

Ashfield Engage’s Ian Riches explains how companies can make patient engagement a priority.

Business & Regulation Profession

Dreams, Chimps, and Chocolate Cakes

| Angus Stewart | 9 min read

ISCT’s new president talks platforms, regulation, and knowledge-transfer for the next generation

Manufacture Facilities

The Grand Challenge: Oligonucleotides Under the Microscope

| Maryam Mahdi | 5 min read

How can pharma companies ensure the future success of the oligonucleotide therapeutic market?

Manufacture Vaccines

Lessons Learned: Leveraging Pandemic Pandemonium for a Better Future

| Bryan Ennis | 7 min read

How can our knowledge of mRNA vaccine development influence our Industry 4.0 journeys?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register